相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glucocorticoid-induced osteoporosis: 2019 concise clinical review
G. Adami et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Asperpyrone A attenuates RANKL-induced osteoclast formation through inhibiting NFATc1, Ca2+ signalling and oxidative stress
Xi Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Madecassoside inhibits estrogen deficiency-induced osteoporosis by suppressing RANKL-induced osteoclastogenesis
Qingqing Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Evodiamine inhibits RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss in mice
Haiming Jin et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Helvolic acid attenuates osteoclast formation and function via suppressing RANKL-induced NFATc1 activation
Kai Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities
Yuhao Liu et al.
THERANOSTICS (2019)
Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen Species
Kai Chen et al.
THERANOSTICS (2019)
Cyanidin Chloride inhibits ovariectomy-induced osteoporosis by suppressing RANKL-mediated osteoclastogenesis and associated signaling pathways
Jianwen Cheng et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Rhaponticin decreases the metastatic and angiogenic abilities of cancer cells via suppression of the HIF-1 pathway
Aeyung Kim et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
SOD2 and Sirt3 Control Osteoclastogenesis by Regulating Mitochondrial ROS
Haemin Kim et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo
Lijun Tao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Rhapontin ameliorates colonic epithelial dysfunction in experimental colitis through SIRT1 signaling
Wencheng Wei et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Change in risk of breast cancer after receiving hormone replacement therapy by considering effect-modifiers: a systematic review and dose-response meta-analysis of prospective studies
Kang Wang et al.
ONCOTARGET (2017)
Overexpression of Heme Oxygenase-1 Prevents Renal Interstitial Inflammation and Fibrosis Induced by Unilateral Ureter Obstruction
Xiao Chen et al.
PLOS ONE (2016)
Bone metastasis: the importance of the neighbourhood
Peter I. Croucher et al.
NATURE REVIEWS CANCER (2016)
Metabolic Regulation of Osteoclast Differentiation and Function
Yoriko Indo et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
WNT signaling in bone homeostasis and disease: from human mutations to treatments
Roland Baron et al.
NATURE MEDICINE (2013)
The role of estrogen and androgen receptors in bone health and disease
Stavros C. Manolagas et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
NFATc1: Functions in osteoclasts
Qingxiao Zhao et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Bisphosphonate-associated osteonecrosis of the jaw. Knowledge and attitudes of dentists and dental students: a preliminary study
Pia Lopez-Jornet et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2010)
Osteoporosis: impact on health and economics
Nicholas Harvey et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
NADPH oxidase-derived reactive oxygen species are essential for differentiation of a mouse macrophage cell line (RAW264.7) into osteoclasts
Hideyuki Sasaki et al.
JOURNAL OF MEDICAL INVESTIGATION (2009)
New regulators of NF-κB in inflammation
Sankar Ghosh et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Osteoclast differentiation and gene regulation
Qingxiao Zhao et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway
Hao Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-κB transactivation by RANKL
H. Huang et al.
CELL DEATH AND DIFFERENTIATION (2006)
Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation
Jung-Min Koh et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
RANKL-RANK signaling in osteoclastogenesis and bone disease
T Wada et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Autoamplification of NFATc1 expression determines its essential role in bone homeostasis
M Asagiri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Heme oxygenase 1 (HO-1) regulates osteoclastogenesis and bone resorption
J Zwerina et al.
FASEB JOURNAL (2005)
A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation
NK Lee et al.
BLOOD (2005)
Adverse outcomes of osteoporotic fractures in the general population
LJ Melton
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappa B activation
C Wang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts
H Takayanagi et al.
DEVELOPMENTAL CELL (2002)
Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-κB ligand
JK Xu et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
RK Ross et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
